4//SEC Filing
Clyburn Frank 4
Accession 0001610717-25-000267
CIK 0001628171other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:23 PM ET
Size
6.7 KB
Accession
0001610717-25-000267
Insider Transaction Report
Form 4
Clyburn Frank
Director
Transactions
- Award
Common Stock
2025-06-26+2,806→ 9,738 total - Award
Stock Option (Right to Buy)
2025-06-26+10,337→ 10,337 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (10,337 underlying)
Footnotes (2)
- [F1]Includes 8,005 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001763963
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:23 PM ET
- Size
- 6.7 KB